Healthcare downgrades and initiations for Monday

Cell Therapeutics (CTIC +8.3%) initiated at Buy at Wainwright. Price target is $4.

Evoke Pharma (EVOK +2.1%) initiated at Buy at Cantor. Price target is $19.

MacroGenics (MGNX +0.8%) initiated at Leerink and BofA at Outperform and Neutral respectively. Price targets are $34 and $30.

AstraZeneca (AZN +0.1%) cut to Neutral from Buy at UBS.

WellCare Health Plans (WCG -0.6%) cut to Neutral from Buy at Monness Crespi.

Teva (TEVA -0.9%) cut to Underweight from Neutral at JPMorgan. Price target to $38 from $43.

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs